IAOCR/GCSA Launches Accredited Clinical Research Certification Programs Across Latin America, Announces Regional Website
Global Gold Standard in Clinical Research Accreditation Now Available to Sites, Professionals, and Sponsors in Latin America
MIAMI, FL — April 22, 2025 — IAOCR (International Accrediting Organization for Clinical Research) and GCSA (Global Clinical Site Assessment), the world’s leading clinical research accreditation bodies, today announced the official launch of their certification programs in Latin America. Supported by the new regional hub at https://iaocramericas.com/, this expansion empowers Latin American clinical research stakeholders to achieve globally recognized standards of excellence, reduce trial risk, and attract international sponsors.
Elevating Latin America’s Clinical Research Ecosystem
For the first time, clinical trial sites, professionals, and organizations in Latin America can access IAOCR’s UNESCO-aligned certifications and GCSA’s patient-centric site assessments—tools already trusted by regulators, sponsors, and CROs in 40+ countries. The launch addresses critical regional challenges, including:
Regulatory fragmentation hindering cross-border collaboration.
Variable site quality delaying trial approvals and patient recruitment.
Limited visibility for Latin American sites in global sponsor networks.
“Latin America is poised to become a clinical research powerhouse, with cancer trial participation alone projected to grow by 66% by 2040,” said Julio G. Martínez, President of IAOCR/GCSA Americas. “By bringing IAOCR/GCSA’s gold-standard certifications to the region, we’re equipping sites and professionals to meet global benchmarks, ensuring safer trials, faster approvals, and stronger partnerships with international sponsors.”
Key Offerings Now Available
IAOCR Professional Accreditation:
Validates individual competence for roles like Clinical Research Coordinators and Investigators.
Lifetime accreditation recognized by regulators, including the FDA and ANVISA.
GCSA Site Certification:
Assesses seven operational pillars, from patient engagement to risk management.
Certified sites gain listing in IAOCR’s global “Partner of Choice” directory, used by top 20 pharma firms.
Sponsor/CRO Solutions:
Pre-qualify Latin American sites with GCSA’s evidence-based assessments, reducing monitoring costs by 30%.
Strategic Regional Partnerships
IAOCR/GCSA Americas has partnered with leading organizations to drive adoption, including:
bioaccess®: Julio Martínez’s CRO, leveraging 15 years of regional trial expertise to support certification readiness.
Government Health Agencies: Collaborating to align national regulations with global standards.
Macondo Labs: Mentoring startups on integrating accreditation into growth strategies.
New Website & Regional Leadership
The launch coincides with the debut of https://iaocramericas.com/, providing Spanish/Portuguese resources for:
Applying for certifications.
Accessing UNESCO-aligned training.
Connecting with IAOCR’s Global Advisory Board (Novartis, Syneos Health, NHS).
“Latin America’s clinical research potential is immense but underleveraged,” said Jacqueline Johnson, IAOCR Global CEO. “With Julio’s leadership and IAOCR/GCSA’s rigorous standards, the region will play a pivotal role in delivering tomorrow’s treatments.”
About IAOCR/GCSA
IAOCR is the world-leader in clinical research accreditation, with standards endorsed by UNESCO and regulators worldwide. GCSA (Global Clinical Site Assessment) certifies clinical trial sites against evidence-based operational benchmarks. Together, they reduce risk, enhance compliance, and accelerate timelines for 1,000+ organizations globally.
